DOI:

EAPCI Focus on GACI, the French Coronary Atheroma and Interventional Cardiology Group

NEWS

The 2014 edition of the EAPCI Fellows Course took place on 11 and 12 July at the European Heart House, featuring updates on the latest standards of PCI. 98 participants from 30 countries including the 2014 EAPCI Grant Winners attended. Slides and webcasts will be made available soon to EAPCI members. Join EAPCI today to benefit from this restricted access.

Attending ESC Congress 2014 in Barcelona from 30 August to 3 September? Be sure to come to the ESC Plaza and find out more about our offers.

The EAPCI congratulates Marc Hartmann, MD, PhD, for being the first to receive his certificate of excellence in training in interventional cardiology using the innovative ESC eLearning platform.

Find out who is who on the new EAPCI Board on our website.

EAPCI Focus on GACI, the French Coronary Atheroma and Interventional Cardiology Group

An interview with the President, René Koning

What does the EAPCI membership mean for a national society?

GACI is growing and dynamic; however, there are still many areas where we can improve our position, and one of them is to have a stronger presence within EAPCI. For us, the EAPCI is very important: we see the value of the many EAPCI educational tools and in particular the EAPCI fellowship programmes, as good training programmes are very important for the further development of our profession. The French interventional fellows are placed in both the public and the private sectors, and we also try to help with fellowships abroad, predominantly in Europe but also in the United States.

What are the current issues related to the national society?

From an historical perspective, many of the pioneers and innovators in interventional medicine have been past presidents of GACI: Jean Marco, Marie-Claude Morice, Alain Cribier and of course Jacques Puel. Our group is quite large, with almost 900 members, and is unique as half of the group works in the private sector while the other half works in the public sector. This is also reflected in the presidency of GACI, with rotating presidents from each sector. To be honest, there is no real difference between the two groups, as all members are interested in scientific research and new technologies.

From a scientific point of view, GACI has always been involved in the early adoption of new technologies. Even today, this is very apparent when one considers the advances in TAVI, OCT, CTO, FFR and bioresorbable scaffolds. GACI has helped to create a national registry called FRANCE ABSORB. We are also moving beyond therapeutic interventional aspects in our practice by addressing the components of atherosclerotic disease (anatomical, biological and functional aspects). Similarly, the development of peripheral angioplasty as practised by interventionalists is another topic of great interest.

Happily, our subspecialty is recognised by the Ministry of Health. We also play an important role in discussions with the Ministry on all aspects of interventional cardiology. This is one of the critical reasons why data from our national registries will help refine our practice as well as improving the quality of our care.

René Koning, President of the French Coronary Atheroma and Interventional Cardiology Group

President: René Koning

President Elect: Hervé Le Breton

Contact details: [email protected]

Website: http://www.sfcardio.fr/groupes/groupes/groupe-atherome-coronaire-et-cardiologie-interventionnelle

Upcoming annual meeting: XVIe Congrès Francophone de Cardiologie Interventionnelle, Paris, 8/10 October 2014

Founded: 1977 (GACI)

Members: 943 interventional members

EAPCI members: 218

Volume 10 Number 4
Aug 19, 2014
Volume 10 Number 4
View full issue


Key metrics

Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved